Literature DB >> 27758159

Comparison of Human Hematopoietic Reconstitution in Different Strains of Immunodeficient Mice.

Ashley I Beyer1, Marcus O Muench1,2.   

Abstract

Immunodeficient mice play a critical role in hematology research as in vivo models of hematopoiesis and immunology. Multiple strains have been developed, but hematopoietic stem cell engraftment and immune reconstitution have not been methodically compared among them. Four mouse strains were transplanted with human fetal bone marrow or adult peripheral blood CD34+ cells: NSG, NSG-3GS, hSCF-Tg-NSG, and hSIRPα-DKO. Hematopoietic engraftment in the bone marrow, blood, spleen, and liver was evaluated by flow cytometry 12 weeks after transplant. The highest levels of human engraftment were observed in the liver, spleen, and bone marrow, whereas peripheral blood cell chimerism was notably less. The highest levels of tissue engraftment were in hSCF-Tg-NSG mice, but NSG mice exhibited the highest blood leukocyte engraftment. hSCF-Tg-NSG mice also exhibited the highest levels of CD133+CD34++ stem cells. hSIRPα-DKO engrafted poorly and exhibited poor breeding. Myelopoiesis was greatest in NSG-3GS mice, followed by hSCF-Tg-NSG and NSG mice, whereas B cell engraftment exhibited the opposite pattern. Engraftment of CD3+ T cells, CD3+CD161+ T cells, and CD3-CD56+ NK cells was greatest in NSG-3GS mice. Mast cell engraftment was highest in hSCF-Tg-NSG mice, but was also elevated in spleen and livers of NSG-3GS mice. Basophils were most abundant in NSG-3GS mice. Overall, hSCF-Tg-NSG mice are the best recipient mice for studies requiring high levels of human hematopoiesis, stem cell engraftment, and an intermediate level of myelopoiesis, whereas NSG and NSG-3GS mice offer select advantages in the engraftment of certain blood cell lineages.

Entities:  

Keywords:  CD133; CD34; HSC; bone marrow; hematopoiesis

Mesh:

Year:  2016        PMID: 27758159      PMCID: PMC5248550          DOI: 10.1089/scd.2016.0083

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  33 in total

1.  Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.

Authors:  J D Cashman; T Lapidot; J C Wang; M Doedens; L D Shultz; P Lansdorp; J E Dick; C J Eaves
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

2.  The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts.

Authors:  V I Rebel; C L Miller; C J Eaves; P M Lansdorp
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

3.  Disparate regulation of human fetal erythropoiesis by the microenvironments of the liver and bone marrow.

Authors:  M O Muench; R Namikawa
Journal:  Blood Cells Mol Dis       Date:  2001 Mar-Apr       Impact factor: 3.039

4.  Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice.

Authors:  F E Nicolini; T L Holyoake; J D Cashman; P P Chu; K Lambie; C J Eaves
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

5.  Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.

Authors:  Hideki Okazawa; Sei-ichiro Motegi; Naoko Ohyama; Hiroshi Ohnishi; Takeshi Tomizawa; Yoriaki Kaneko; Per-Arne Oldenborg; Osamu Ishikawa; Takashi Matozaki
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

6.  Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice.

Authors:  J D Cashman; C J Eaves
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

7.  Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes.

Authors:  L L Lanier; C Chang; J H Phillips
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

8.  A quantitative assessment of the content of hematopoietic stem cells in mouse and human endosteal-bone marrow: a simple and rapid method for the isolation of mouse central bone marrow.

Authors:  Maya M Mahajan; Betty Cheng; Ashley I Beyer; Usha S Mulvaney; Matt B Wilkinson; Marina E Fomin; Marcus O Muench
Journal:  BMC Hematol       Date:  2015-07-09

9.  CD161-expressing human T cells.

Authors:  Joannah R Fergusson; Vicki M Fleming; Paul Klenerman
Journal:  Front Immunol       Date:  2011-08-30       Impact factor: 7.561

10.  The adult livers of immunodeficient mice support human hematopoiesis: evidence for a hepatic mast cell population that develops early in human ontogeny.

Authors:  Marcus O Muench; Ashley I Beyer; Marina E Fomin; Rahul Thakker; Usha S Mulvaney; Masato Nakamura; Hiroshi Suemizu; Alicia Bárcena
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more
  10 in total

Review 1.  Mouse models in hematopoietic stem cell gene therapy and genome editing.

Authors:  Stefan Radtke; Olivier Humbert; Hans-Peter Kiem
Journal:  Biochem Pharmacol       Date:  2019-11-06       Impact factor: 5.858

2.  Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies.

Authors:  Katrin Kleinmanns; Stein-Erik Gullaksen; Geir Bredholt; Ben Davidson; Cecilie Fredvik Torkildsen; Sindre Grindheim; Line Bjørge; Emmet McCormack
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

3.  EK-16A liposomes enhance HIV replication in ACH2 or J-Lat 10.6 cell engrafted NSG mice.

Authors:  Panpan Lu; Jinlong Yang; Xinyi Yang; Zhiming Liang; Jing Wang; Yanan Wang; Lin Zhao; Hanyu Pan; Xiaoting Shen; Yuqi Zhu; Jingna Xun; Hongzhou Lu; Huanzhang Zhu
Journal:  Nanotheranostics       Date:  2022-03-21

Review 4.  The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents.

Authors:  Y Maurice Morillon; Ariana Sabzevari; Jeffrey Schlom; John W Greiner
Journal:  Anticancer Res       Date:  2020-10       Impact factor: 2.480

5.  μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.

Authors:  Hannah S Sperber; Padma Priya Togarrati; Kyle A Raymond; Mohamed S Bouzidi; Renata Gilfanova; Alan G Gutierrez; Marcus O Muench; Satish K Pillai
Journal:  FASEB J       Date:  2020-09-09       Impact factor: 5.191

6.  Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells.

Authors:  Gülen Güney-Esken; Özgür Doğuş Erol; Burcu Pervin; Gülben Gürhan Sevinç; Tamer Önder; Elif Bilgiç; Petek Korkusuz; Ayşen Günel-Özcan; Duygu Uçkan-Çetinkaya; Fatima Aerts-Kaya
Journal:  Stem Cell Res Ther       Date:  2021-05-13       Impact factor: 6.832

7.  Improved multilineage human hematopoietic reconstitution and function in NSGS mice.

Authors:  Mark Wunderlich; Fu-Sheng Chou; Christina Sexton; Pietro Presicce; Claire A Chougnet; Julio Aliberti; James C Mulloy
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

8.  In Vivo Clonal Analysis Reveals Random Monoallelic Expression in Lymphocytes That Traces Back to Hematopoietic Stem Cells.

Authors:  Nadiya Kubasova; Clara F Alves-Pereira; Saumya Gupta; Svetlana Vinogradova; Alexander Gimelbrant; Vasco M Barreto
Journal:  Front Cell Dev Biol       Date:  2022-08-08

9.  Immunodeficient mice are better for modeling the transfusion of human blood components than wild-type mice.

Authors:  Sophia A Blessinger; Johnson Q Tran; Rachael P Jackman; Renata Gilfanova; Jacqueline Rittenhouse; Alan G Gutierrez; John W Heitman; Kelsey Hazegh; Tamir Kanias; Marcus O Muench
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

Review 10.  The Origin of B-cells: Human Fetal B Cell Development and Implications for the Pathogenesis of Childhood Acute Lymphoblastic Leukemia.

Authors:  Thomas R Jackson; Rebecca E Ling; Anindita Roy
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.